Myxedema coma presenting with seizures, pericardial effusion, and rhabdomyolysis

Authors

DOI:

https://doi.org/10.17533/udea.iatreia.81

Keywords:

coma, emergencies, endocrine system diseases, hypothyroidism, myxedema

Abstract

Myxedema coma is the most serious complication of hypothyroidism. It usually occurs in the context of elderly women, with known hypothyroidism without proper management and in the presence of a triggering event. The diagnosis is challenging and must be made in a timely manner to prevent the development of adverse outcomes. Coma is one of the neurological manifestations of the entity, not being necessary for its diagnosis. This case report presents a constellation of unusual manifestations of a male patient with myxedema coma at the debut of severe hypothyroidism with predictors of poor prognosis during hospitalization, but due to the early approach and comprehensive management, this uncommon endocrinological emergency was satisfactorily resolved.

|Abstract
= 1395 veces | PDF (ESPAÑOL (ESPAÑA))
= 394 veces| | HTML (ESPAÑOL (ESPAÑA))
= 102 veces|

Downloads

Download data is not yet available.

Author Biographies

Juan Sebastián Peinado-Acevedo, University of Antioquia, San Vicente Foundation University Hospital

Department of Internal Medicine, San Vicente Foundation University Hospital.

 

 

Luis Antonio Rodríguez-Arrieta, University of Antioquia

Clinical Endocrinology and Metabolism.

Carlos Alfonso Builes-Barrera, University of Antioquia, San Vicente Foundation University Hospital

Clinical Endocrinology and Metabolism. Endocrinology and Diabetes Department, San Vicente Foundation University Hospital.

Alejandro Román-González, University of Antioquia, San Vicente Foundation University Hospital

Endocrinology and Metabolism. Endocrinology and Diabetes Department, San Vicente Foundation University Hospital.

References

(1) Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin North Am. 2012;96:385-403. DOI 10.1016/j.mcna.2012.01.015.

(2) Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y. Clinical characteristics and outcomes of myxedema coma: analysis of a national inpatient database in Japan. J Epidemiol 2017;27:117-22. DOI 10.1016/j.je.2016.04.002.

(3) Rodriguez I, Fluiters E, Perez-Mendez LF, Luna R, Paramo C, Garcia-Mayor RV. Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol. 2004;180:347e350. DOI 10.1677/joe.0.1800347.

(4) Jonklaas J, Bianco AC, Bauer AJ, Burman KD, Cappola AR, Celi F, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24:1670e1751. DOI 10.1089/thy.2014.0028.

(5) Dubbs SB, Spangler R. Hypothyroidism: causes, killers, and life-saving treatments. Emerg Med Clin N Am. 2014;32:303e317. DOI 10.1016/j.emc.2013.12.003.

(6) Yamamoto T, Fukuyama J, Fujiyoshi A. Factors associated with mortality of myxedema coma: report of eight cases and literature survey. Thyroid. 1999;9:1167–74. DOI 10.1089/thy.1999.9.1167.

(7) Wartofsky L, Klubo-Gwiezdzinska J. Myxedema Coma. In: Luster M, Duntas L, Wartofsky L. (eds) The Thyroid and Its Diseases. Berlín: Springer Cham; 2019.

(8) Sindoni A, Rodolico C, Pappalardo MA, Portaro S, Benvenga S. Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature. Rev Endocr Metab Disord. 2016;17(4):499-519. DOI 10.1007/s11154-016-9357-0.

(9) Ordookhani A, Burman KD. Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders. Int J Endocrinol Metab. 2017;15(2):e42649. Published 2017 Mar 9. DOI 10.5812/ijem.42649.

(10) Soh SB, Aw TC. Laboratory Testing in Thyroid Conditions - Pitfalls and Clinical Utility. Ann Lab Med. 2019 Jan;39(1):3-14. DOI 10.3343/alm.2019.39.1.3.

(11) Liamis G, Filippatos TD, Liontos A, Elisaf MS. MANAGEMENT OF ENDOCRINE DISEASE: Hypothyroidismassociated hyponatremia: mechanisms, implications and treatment. Eur J Endocrinol. 2017;176(1):R15-R20. DOI 10.1530/EJE-16-0493.

(12) Dutta P, Bhansali A, Masoodi SR, Bhadada S, Sharma N, Rajput R. Predictors of outcome in myxoedema coma: a study from a tertiary care centre. Crit Care. 2008;12(1):R1. DOI 10.1186/cc6211.

(13) Popoveniuc G, Chandra T, Sud A, Sharma M, Blackman MR, Burman KD et al. A diagnostic scoring system for myxedema coma. Endocr Pract. 2014;20(8):808-817. DOI 10.4158/EP13460.OR.

(14) Chiong YV, Bammerlin E, Mariash CN. Development of an objective tool for the diagnosis of myxedema coma. Transl Res. 2015;166(3):233-243. DOI 10.1016/j.trsl.2015.01.003.

(15) Klubo-Gwiezdzinska J, Wartofsky L. Thyroid emergencies. Med Clin North Am. 2012;96(2):385-403. DOI 10.1016/j.mcna.2012.01.015.

(16) McDermott MT. Hypothyroidism. Ann Intern Med. 2020;173(1):ITC1-ITC16. DOI 10.7326/AITC202007070.

(17) Spitzweg C, Reincke M, Gärtner R. Schilddrüsennotfälle. Thyroid emergencies: Thyroid storm and myxedema coma. Internist (Berl). 2017 Oct;58(10):1011-19. DOI 10.1007/s00108-017-0306-0.

(18) Ono Y, Ono S, Yasunaga H, Matsui H, Fushimi K, Tanaka Y. Clinical characteristics and outcomes of myxedema coma: Analysis of a national inpatient database in Japan. J Epidemiol. 2017;27(3):117-122. DOI 10.1016/j.je.2016.04.002.

Published

2020-10-20

How to Cite

1.
Peinado-Acevedo JS, Rodríguez-Arrieta LA, Builes-Barrera CA, Román-González A. Myxedema coma presenting with seizures, pericardial effusion, and rhabdomyolysis. Iatreia [Internet]. 2020 Oct. 20 [cited 2025 Jan. 22];34(1):78-83. Available from: https://revistas.udea.edu.co/index.php/iatreia/article/view/341540

Issue

Section

Case reports

Most read articles by the same author(s)